SavedAdd your journal

Journals / Journal of Surgery and Medicine / 2021 / Cilt: 5 - Sayı: 12

The effect of Covid-19 pandemic on gastric cancer surgery

Nidal İFLAZOĞLU
Ömer YALKIN
Pages
1210–1213
Publication Date
2021-12-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The length of the surgery was statistically significantly longer and the estimated blood loss (cc) was lower in during-COVID-19 period (P

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aim: The global spread of the COVID-19 pandemic has led to difficulties in the prevention of other diseases and especially in the maintenance of cancer treatment, along with the attempts to control the pandemic.
📊
Key Findings & Data:The present study aims to investigate the clinical, oncological, and financial effects of COVID-19 on patients undergoing radical gastric cancer surgery.
💡
Conclusion & Impact:The length of the surgery was statistically significantly longer and the estimated blood loss (cc) was lower in during-COVID-19 period (P
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Gastric cancer · Surgery · COVID-19

Abstract

Background/Aim: The global spread of the COVID-19 pandemic has led to difficulties in the prevention of other diseases and especially in the maintenance of cancer treatment, along with the attempts to control the pandemic. The present study aims to investigate the clinical, oncological, and financial effects of COVID-19 on patients undergoing radical gastric cancer surgery. Methods: This retrospective cohort study included 46 patients and the clinical, epidemiological, radiological, and laboratory data of these patients were analyzed. Inclusion criteria were patients who were diagnosed with gastric cancer, who underwent radical surgical resection in pre-COVID-19 and during COVID-19 periods. Appropriate surgical options were used by taking precautions against viral transmission. Results: Of the study patients, 56.5% were males, the median age was 69 (42–83) years, and the median length of stay was 9 (7–34) days. The rate of thoracic computed tomography (CT) taken was statistically significantly higher in during-COVID-19 period (P=0.008). The length of the surgery was statistically significantly longer and the estimated blood loss (cc) was lower in during-COVID-19 period (P

🔖

Cite This Article

İFLAZOĞLU, N., YALKIN, Ö. (2021). The effect of Covid-19 pandemic on gastric cancer surgery. Journal of Surgery and Medicine, Cilt: 5 - Sayı: 12, 1210–1213. https://ajindex.com/articles/779784

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Yusefi A, BagheriLankarani K, Bastani P, RadinManesh M, Kavosi Z. Risk factors for gastric cancer: a systematic review. Asian pac j cancer prev. 2018;19(3):591–03
  2. Jindal V, Sahu KK, Gaikazian S, Siddiqui AD, Jaiyesimi I. Cancer treatment during COVID-19 pandemic. Med Oncol. 2020;37(7):58
  3. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335-7
  4. Rosa F, Alfieri S. Possible impact of COVID-19 on gastric cancer surgery in Italy. Minerva Chir. 2020;75(5):380-1
  5. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187-96
  6. Li Y, Qin JJ, Wang Z, Yu Y, Wen YY, Chen XK, et al. Surgical treatment for esophageal cancer during the outbreak of COVID-19. ZhonghuaZhong Liu ZaZhi. 2020;42(4): 296-300 7. Kang WZ, Zhong YX, Ma FH, Liu H, Ma S, Li Y, et al. Treatment strategies for gastric cancer during the COVID-19 pandemic. World J Clin Cases. 2020;8(21):5099-03
  7. Ma FH, Hu HT, Tian YT. Surgical treatment strategy for digestive system malignancies during the outbreak of novel coronavirus pneumonia. ZhonghuaZhong Liu ZaZhi. 2020;42(3):180-3
  8. Liu Y, Zhang KC, Huang XH, Xi HQ, Gao YH, Liang WQ et al.Timing of surgery after neoadjuvant chemotherapy for gastric cancer: Impact on outcomes. World J Gastroenterol. 2018;24(2):257-65
  9. Morais S, Antunes L, Rodrigues J, Fontes F, Bento MJ, Lunet N. The impact of the COVID-19 pandemic on the short-term survival of patients with cancer in Northern Portugal. Int J Cancer. 2021;149(2):287-96
  10. Chen YH, Peng JS. Treatment strategy for gastrointestinal tumor under the outbreak of novel coronavirus pneumonia in China. Zhonghua Wei Chang WaiKeZaZhi. 2020;23(2):1-4
  11. Tuech JJ, Gangloff A, Di Fiore F, Michel P, Brigand C, Slim K, et al.Strategy for the practice of digestive and oncological surgery during Covid-19 epidemic. J ViscSurg. 2020;153(3):7-12 13. Aznab M. Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic. Int J ClinOncol. 2020;25(9):1581-6
  12. Carmona-Bayonas A, Jiménez-Fonseca P, VirizuelaEchaburu J, Antonio M, Font C, Biosca M, et al. Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients